Biopharma acquisition activity in 2018 shows a significant increase over the previous year. Takeda proved to be on top with the acquisition of Shire among the top 20 acquisitions with […]readmore
Tags : Endocyte
Shots: Endocyte to receive $24M/share in cash with total deal value of $2.1B. Novartis to get hold of all stocks with its RLT candidates Lu-PSMA-617 & Ac-PSMA-617 Lu-PSMA-617 is a […]readmore